Stock Scorer

OneMedNet Corp (ONMD)

OneMedNet Corp reported revenue of 292K USD for the quarter ending 30 June 2026, up 88.4% from 155K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 292K +88.4%
Gross Profit Q2 '26 · ending 30 June 2026 -565K —
Operating Income Q2 '26 · ending 30 June 2026 -2.3M —
Net Income Q2 '26 · ending 30 June 2026 -2.2M -172.8%
Cost of Revenue Q2 '26 · ending 30 June 2026 857K +116.4%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -1.9M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -1.9M —
Shares Outstanding Q2 '26 · ending 30 June 2026 58M +70.1%
EPS Q2 '26 · ending 30 June 2026 -0.16 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1.4M-9.7M-2.8M-7.5M
20242024-12-31 643K-9.6M-10.1M-7M
20232023-12-31 1M-6.9M-33.8M-4.8M
20222022-12-31 1.2M-7.7M-30.5M-4.8M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30292K
Q1 '262026-03-3196K
Q4 '252025-12-31891K
Q3 '252025-09-30177K
Q2 '252025-06-30155K
Q1 '252025-03-31137K
Q4 '242024-12-3126K
Q3 '242024-09-30142K
Q2 '242024-06-30227K
Q1 '242024-03-31248K
Q4 '232023-12-31340K
Q3 '232023-09-30326K
Q2 '232023-06-30173K
Q1 '232023-03-31200K
Q4 '222022-12-31264K
Q3 '222022-09-30375K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30-565K
Q1 '262026-03-31-380K
Q4 '252025-12-31184K
Q3 '252025-09-30-222K
Q2 '252025-06-30-241K
Q1 '252025-03-31-224K
Q4 '242024-12-31-26K
Q3 '242024-09-30-84K
Q2 '242024-06-30-102K
Q1 '242024-03-31-69K
Q4 '232023-12-31-16K
Q3 '232023-09-3033K
Q2 '232023-06-30-57K
Q1 '232023-03-31-89K
Q4 '222022-12-31-143K
Q3 '222022-09-30-99K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-2.3M
Q1 '262026-03-31-2.6M
Q4 '252025-12-31-3.1M
Q3 '252025-09-30-2.2M
Q2 '252025-06-30-2.1M
Q1 '252025-03-31-2.2M
Q4 '242024-12-31-2.7M
Q3 '242024-09-30-2.3M
Q2 '242024-06-30-2.5M
Q1 '242024-03-31-2.1M
Q4 '232023-12-31-1.9M
Q3 '232023-09-30-1.9M
Q2 '232023-06-30-1.6M
Q1 '232023-03-31-1.5M
Q4 '222022-12-31-1.9M
Q3 '222022-09-30-520K
Q2 '222022-06-30-794.5K
Q1 '222022-03-31-610.2K
Q4 '212021-12-31-415.3K
Q3 '212021-09-30-98.7K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-2.2M
Q1 '262026-03-31-2.5M
Q4 '252025-12-31-3.1M
Q3 '252025-09-30-741K
Q2 '252025-06-303M
Q1 '252025-03-31-1.9M
Q4 '242024-12-31-2.4M
Q3 '242024-09-30-2.1M
Q2 '242024-06-30-3.6M
Q1 '242024-03-31-2.1M
Q4 '232023-12-31-2.5M
Q3 '232023-09-30-13.8M
Q2 '232023-06-30-9.6M
Q1 '232023-03-31-7.8M
Q4 '222022-12-31-8.1M
Q3 '222022-09-30-153.3K
Q2 '222022-06-30949.9K
Q1 '222022-03-312.2M
Q4 '212021-12-31-464.5K
Q3 '212021-09-301.3M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30857K
Q1 '262026-03-31476K
Q4 '252025-12-31726K
Q3 '252025-09-30399K
Q2 '252025-06-30396K
Q1 '252025-03-31361K
Q4 '242024-12-3152K
Q3 '242024-09-30226K
Q2 '242024-06-30329K
Q1 '242024-03-31317K
Q4 '232023-12-31338K
Q3 '232023-09-30293K
Q2 '232023-06-30230K
Q1 '232023-03-31289K
Q4 '222022-12-31407K
Q3 '222022-09-30474K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-1.9M
Q1 '262026-03-31-1.5M
Q4 '252025-12-31-1.7M
Q3 '252025-09-30-1.7M
Q2 '252025-06-30-2.2M
Q1 '252025-03-31-1.9M
Q4 '242024-12-31-2M
Q3 '242024-09-30-1.9M
Q2 '242024-06-30-1.5M
Q1 '242024-03-31-1.5M
Q4 '232023-12-31-1.7M
Q3 '232023-09-30-1.1M
Q2 '232023-06-30-964K
Q1 '232023-03-31-1M
Q4 '222022-12-31-1.3M
Q3 '222022-09-30-2.9M
Q2 '222022-06-30-151.7K
Q1 '222022-03-31-294K
Q4 '212021-12-31-80.6K
Q3 '212021-09-30-268.4K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-1.9M
Q1 '262026-03-31-1.5M
Q4 '252025-12-31-1.7M
Q3 '252025-09-30-1.7M
Q2 '252025-06-30-2.2M
Q1 '252025-03-31-1.9M
Q4 '242024-12-31-2M
Q3 '242024-09-30-1.9M
Q2 '242024-06-30-1.5M
Q1 '242024-03-31-1.6M
Q4 '232023-12-31-1.7M
Q3 '232023-09-30-1.1M
Q4 '222022-12-31-1.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3058M
Q1 '262026-03-3155.3M
Q3 '252025-09-3052.6M
Q2 '252025-06-3038.4M
Q1 '252025-03-3134.1M
Q3 '242024-09-3029.3M
Q2 '242024-06-3025.2M
Q1 '242024-03-3124.9M
Q3 '232023-09-304.3M
Q2 '232023-06-304M
Q1 '232023-03-314M
Q3 '222022-09-304.3M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.16
Q1 '262026-03-31-0.05
Q4 '252025-12-31-0.07
Q3 '252025-09-30-0.07
Q2 '252025-06-30-0.13
Q1 '252025-03-31-0.34
Q4 '242024-12-31-0.36
Q3 '242024-09-302.61
Q2 '242024-06-30-0.55
Q1 '242024-03-31-2.79
Q4 '232023-12-31-4.65
Q3 '232023-09-30-10.19